comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 01:35:36 - browse：79478

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Having children helps parents live longer, especially after age 80

WSS

Latigo launches with $135 million for Vertex

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Medical school prerequisites are outdated

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Resistance to opioid

AMAs digital advisors table RPM coding reform proposal, again

knowledge

comprehensive

entertainment

Apple is now the first public company to be valued at $3 trillion

Bernie Sanders gets little from pharma CEOs on drug prices

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cancer diagnosis changes perspective doctor, former hospital CEO

In age of alternative facts, a scholarly course on calling out crap

Ventyx halts psoriasis drug development after lackluster trial results

Cancer drug shortages should be causing more outrage

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Affirmative action in medical school literally saved lives

Artificial intelligence use in health care faces greater scrutiny in 2024

focus

Carbon Health diabetes program, a test of data

Juul documents reveal insider tactics on political lobbying

Weight loss drugs should be covered by insurers, AMA says

Medical school prerequisites are outdated

After decades in use, heart stents finally beat placebo

Medicare’s new pay boost for primary care is angering specialists

hotspot

leisure time

explore

Wikipedia